Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
CD Protein Inhibitors
>>
Phase 1
«
1
2
3
4
5
6
7
8
9
10
11
12
13
»
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
1
2
3
4
5
6
7
8
9
10
JNJ-8343
/ J&J
JNJ-90009530
/ J&J
LMY-920
/ Luminary Therap
LUCAR-20S CAR-T cells
/ Legend Biotech
NG-641
/ Akamis Bio
NIP-022
/ Nissan Chemical Corp
OBT076
/ Menarini, Oxford BioTherap
ONO-4685
/ Ono Pharma
PM8001
/ Biotheus
Senl 1904B
/ SenlangBio
TT11X
/ Tessa Therap
UCART19
/ Allogene Therap, Servier
WTX212
/ Westlake Therap
ZB-168
/ Zura Bio
autologous anti-CD19 (human derived) chimeric antigen receptor T cells
/ Beijing Boren Hospital
efbalropoendekin alfa
(RG6323) / Roche
pradusinstobart
(LVGN3616) / Lyvgen
vixtimotamab
(AMV564) / Affimed
211At-OKT10-B10
/ Fred Hutchinson Cancer Center
225Ac-DOTA-daratumumab
/ City of Hope
A-319
/ ITabMed
A-337
/ ITabMed
AFM11
/ Affimed
AGS67E
/ Astellas, Pfizer
AMP-224
/ GSK
APVO436
/ Aptevo Therap
ATA3219
/ Atara
ATG-101
/ Antengene
Autologous CAR-T cells
/ UTC Therap
BAT4306F
/ Bio-Thera Solutions
BAT7104
/ Bio-Thera Solutions
BCMA-CD19 cCAR T cells
/ iCell Gene Therap
BGB-B167
/ BeiGene
BI 765049
/ Boehringer Ingelheim
BRL-201
/ BRL Medicine
BS006
/ Wuhan Binhui Biotech
C7R-GD2.CART cells
/ Baylor College of Medicine
CART123
/ University of Pennsylvania
CB307
/ Crescendo Biologics
CC-90002
/ Inhibrx, BMS
CC-90006
/ BMS
CD147-CART
/ Air Force Medical University
CD19 Universal Chimeric Antigen Receptor T Cell
/ Suzhou Maximum Bio-tech
CD19-TriCAR-SILK therapy
/ Timmune Biotech
CD19CAR-28-zeta T cells
/ Baylor College of Medicine
CD19CAR/virus specific T cell therapy
/ Baylor College of Medicine
CD200AR-L
/ OX2 Therap
CD33 CAR-T
/ Hedy Group, Zhejiang University
CD7 CAR-T Cell
/ iCell Gene Therap
CD8+NKG2D+ AKT cell immunotherapy
/ iCELL Biotechnology
«
1
2
3
4
5
6
7
8
9
10
11
12
13
»
